logo-loader
viewNetscientific PLC

Notice of AGM and Annual Report & Accounts

/**/ p{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: #0563C1 }visited{ color: #954F72 } .an{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.an{}p.bt{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm}p.bu{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: center}p.bv{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";line-height: normal; margin-bottom: 0cm; text-align: center}p.bw{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; text-align: center}span.bo{font-size:12.0pt}p.bx{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; text-align: justify}span.bm{font-size: 12.0pt}p.by{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align:justify} span.bk{color:black}span.bi{background:white}p.bz{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-div: italic; line-height: normal; margin-bottom: 0cm; text-align: justify}p.ca{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align:justify}p.cb{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold}span.bg{font-size:10.0pt;line-height:107%; color:black}table.cc{width:459.75pt;margin-left:-5.4pt;border-collapse:collapse}tr.ax{height:28.7pt}td.ba{width:280.5pt;padding:0cm 5.4pt 0cm 5.4pt;height:28.7pt}p.a,li.a,div.a{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";} span.be{font-size:10.0pt;line-height:107%}p.cd{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";background:white}span.bd{font-size: 10.0pt;line-height:107%}span.bc{font-size:10.0pt; line-height:107%}td.ay{width:157.65pt;padding:0cm 5.4pt 0cm 5.4pt;height:28.7pt}p.ce{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align: right}tr.as{height:29.1pt}td.au{width:280.5pt;padding:0cm 5.4pt 0cm 5.4pt;height:29.1pt}p.cf{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; margin-left: 7.1pt}p.cg{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-left:7.1pt} td.at{width:157.65pt;padding:0cm 5.4pt 0cm 5.4pt;height:29.1pt}p.ch{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; text-align: justify}span.aq{font-size:10.0pt; line-height:107%;color:black}span.ap{font-size: 10.0pt;line-height:107%;color:blue}p.ci{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 0cm; text-align: justify} /**/
RNS Number : 1237A
NetScientific PLC
24 May 2019
 

 

 

NetScientific plc

("NetScientific" or the "Company" or the "Group")

 

 

Notice of AGM and Annual Report & Accounts

 

London, UK - 24 May 2019 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that, in accordance with AIM Rules 20 and 26, the Group's Annual Report and Accounts for the year ended 31 December 2018 and Notice of Annual General Meeting have been sent to shareholders today and are available on the Company's website in the Investor Relations section at http://www.netscientific.net/investors.

 

The Annual General Meeting of the Group will be held on Tuesday, 18 June 2019 at 12.00 p.m. at Ashurst LLP, 1 Duval Square, London Fruit and Wool Exchange, London E1 6PW, United Kingdom.

 

#  #  #

 

For more information, please contact:

 

  NetScientific

  Ian Postlethwaite, CEO

Tel: +44 (0)20 3514 1800

 

WHIreland (NOMAD, Financial Adviser and Broker)

Chris Fielding / Jessica Cave

 Tel: +44 (0)20 7220 1666

 

 

About NetScientific

 

NetScientific PLC is a transatlantic healthcare IP commercialisation Group focused on technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people.

 

 

For more information, please visit the website at www.NetScientific.net

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ACSEAPSLALSNEEF

Quick facts: Netscientific PLC

Price: 6

Market: AIM
Market Cap: £4.71 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: ANGLE reports positive data from Parsortix FDA clinical study

Top stories from the Proactive Investors UK newsroom: ANGLE PLC (LON:AGL) has received positive results from its Parsortix FDA clinical study for metastatic breast cancer. The 400-subject clinical study will support an application for Class II regulatory clearance for Parsortix in the...

on 31/5/19